Antiphospholipid syndrome treated with prednisolone, cyclophosphamide and double-filtration plasmapheresis

13Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

A case of antiphospholipid syndrome (APS) is reported. A 48-year-old man visited our hospital because of proteinuria. He had suffered from thrombosis and had high titers of antibodies to β2-glycoprotein I (aβ2GPI) and anticardiolipin antibodies (aCLIgG) and thrombocytopenia. We started anticoagulation therapy using warfarin combined with prednisolone. Although platelet count was improved, the titers of anti-β2GPI and aCLIgG still remained high. Therefore, double-filtration plasmapheresis (DFPP) was carried out to remove the antibodies. After the treatment with DFPP, cyclophosphamide was administered. These therapies resulted in lower titers of aβ2GPI and aCLIgG and no more thrombosis occurred. A combination therapy using warfarin, prednisolone, cyclophosphamide and DFPP might be effective for the treatment of patients with APS.

Cite

CITATION STYLE

APA

Otsubo, S., Nitta, K., Yumura, W., Nihei, H., & Mori, N. (2002). Antiphospholipid syndrome treated with prednisolone, cyclophosphamide and double-filtration plasmapheresis. Internal Medicine, 41(9), 725–729. https://doi.org/10.2169/internalmedicine.41.725

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free